--- title: "Okta To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday" type: "News" locale: "en" url: "https://longbridge.com/en/news/296491796.md" description: "Cantor Fitzgerald raised Okta's price target from $125 to $170, maintaining an Overweight rating. Other analyst updates include Keefe, Bruyette & Woods upgrading Progressive Corp and raising its target; Morgan Stanley upgrading Merck & Co and significantly increasing its target; and Needham raising Analog Devices' target. Conversely, Ascendiant Capital lowered Travelzoo's target. These changes reflect shifting Wall Street outlooks on various tech, healthcare, and insurance stocks." datetime: "2026-08-20T12:19:57.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296491796.md) - [en](https://longbridge.com/en/news/296491796.md) - [zh-HK](https://longbridge.com/zh-HK/news/296491796.md) generator: "portal-rs" --- # Okta To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. - Keefe, Bruyette & Woods raised the price target for **Progressive Corp** (NYSE:PGR) from $226 to $250. Keefe, Bruyette & Woods analyst Meyer Shields upgraded the stock from Market Perform to Outperform. Progressive shares closed at $217.27 on Wednesday. See how other analysts view this stock. - Cantor Fitzgerald boosted **Ultragenyx Pharmaceutical Inc** (NASDAQ:RARE) price target from $96 to $103. Cantor Fitzgerald analyst Kristen Kluska maintained an Overweight rating. Ultragenyx Pharmaceutical shares closed at $26.24 on Wednesday. See how other analysts view this stock. - Ascendiant Capital slashed price target for **Travelzoo** (NASDAQ:TZOO) from $23 to $20. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Travelzoo shares closed at $6.88 on Wednesday. See how other analysts view this stock. - Needham increased the price target for **Analog Devices Inc** (NASDAQ:ADI) from $440 to $450. Needham analyst N. Quinn Bolton maintained a Buy rating. Analog Devices shares closed at $373.26 on Wednesday. See how other analysts view this stock. - Morgan Stanley raised **Merck & Co Inc** (NYSE:MRK) price target from $116 to $179. Morgan Stanley analyst Terence Flynn upgraded the stock from Equal-Weight to Overweight. Merck shares closed at $152.20 on Wednesday. See how other analysts view this stock. - BTIG increased **Glaukos Corp** (NYSE:GKOS) price target from $193 to $202. BTIG analyst Ryan Zimmerman maintained a Buy rating. Glaukos shares closed at $189.55 on Wednesday. See how other analysts view this stock. - Morgan Stanley raised **Moderna Inc** (NASDAQ:MRNA) price target from $39 to $89. Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating. Moderna shares closed at $174.38 on Wednesday. See how other analysts view this stock. - Needham raised the price target for **NIQ Global Intelligence PLC** (NYSE:NIQ) from $18 to $21. Needham analyst Kyle Peterson maintained a Buy rating. NIQ Global Intelligence shares closed at $18.31 on Wednesday. See how other analysts view this stock. - Cantor Fitzgerald raised **Okta Inc** (NASDAQ:OKTA) price target from $125 to $170. Cantor Fitzgerald analyst Jonathan Ruykhaver maintained an Overweight rating. Okta shares closed at $141.21 on Wednesday. See how other analysts view this stock. - Cantor Fitzgerald raised **Rubrik Inc** (NYSE:RBRK) price target from $95 to $120. Cantor Fitzgerald analyst Jonathan Ruykhaver maintained an Overweight rating. Rubrik shares closed at $99.78 on Wednesday. See how other analysts view this stock. Considering buying OKTA stock? Here’s what analysts think: *Photo via Shutterstock* ### Related Stocks - [PGR.US](https://longbridge.com/en/quote/PGR.US.md) - [OKTA.US](https://longbridge.com/en/quote/OKTA.US.md) - [TZOO.US](https://longbridge.com/en/quote/TZOO.US.md) - [ADI.US](https://longbridge.com/en/quote/ADI.US.md) - [MRK.US](https://longbridge.com/en/quote/MRK.US.md) - [OKTX.US](https://longbridge.com/en/quote/OKTX.US.md) - [RARE.US](https://longbridge.com/en/quote/RARE.US.md) - [GKOS.US](https://longbridge.com/en/quote/GKOS.US.md) - [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md) - [NIQ.US](https://longbridge.com/en/quote/NIQ.US.md) - [RBRK.US](https://longbridge.com/en/quote/RBRK.US.md) ## Related News & Research - [Analog Devices Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call](https://longbridge.com/en/news/296218304.md) - [These Analysts Revise Their Forecasts On Analog Devices After Q3 Earnings](https://longbridge.com/en/news/296515974.md) - [Okta’s AI Tailwind Could Put This Forgotten Software Stock Back in Play](https://longbridge.com/en/news/296379793.md) - [New Buy Rating for Okta (OKTA), the Technology Giant](https://longbridge.com/en/news/296590659.md) - [Analog Devices Earnings Could Trigger a Move as Options Price in Modest Volatility](https://longbridge.com/en/news/296049013.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**